Regular magnetic resonance imaging evaluations show that only about half of patients with multiple sclerosis achieve and sustain a response to treatment with interferon beta over three years, according to a new study in the Archives of Neurology.
Regular magnetic resonance imaging evaluations show that only about half of patients with multiple sclerosis achieve and sustain a response to treatment with interferon beta over three years, according to a new study in the Archives of Neurology.